Data / Form D filings / ADVAC Therapeutics Inc
ADVAC Therapeutics Inc: Form D filing
ADVAC Therapeutics Inc, a pharmaceuticals company in Columus, OH, filed a Form D with the SEC in 2026. The latest, on March 10, 2026, reports $500,000 sold of a $5 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2281 Kenny Road SUITE 410, Columus, OH, 43210
- Phone
- (908) 285-3087
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2022
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2115406
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 10, 2026 | New notice | $5,000,000 | $500,000 | $4,500,000 | 1 | Feb 6, 2026 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Mark Walter Gossett | Executive Officer, Director |
Other pharmaceuticals companies in Ohio that filed recently
- EIKONOKLASTES THERAPEUTICS, INC. $16.1 million · Oct 6, 2026
Every Form D from the week of Mar 9, 2026 · All recent filings in Ohio · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what ADVAC Therapeutics Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.